Weight Loss Study With Two New Injectable Medications
Treatments studied
Part of Hormones & metabolism clinical trials.
This study tests two new injectable drugs (macupatide and eloralintide) alone or together to help adults with obesity or excess weight lose weight. The goal is to see if these medications are safe and effective for weight management.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have obesity or are overweight (body weight above a certain threshold)
- You do not have type 1 or type 2 diabetes
- You do not have a history of pancreatitis (inflammation of the pancreas)
- Your resting heart rate is between 60 and 100 beats per minute
- You do not have bradycardia or irregular heartbeats related to slow heart rate
- Any regular medications you take must have been at the same dose for at least 3 months before screening
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an investigational drug called macupatide to see if it can help people with overweight or obesity lose weight. It is for people who do not have type 2 diabetes and are in generally good health.
This trial tests an experimental drug (Eloralintide) to see if it can help with weight management. It is for people who have a body mass index (BMI) between 25 and 45 and stable weight.
This study tests an experimental medicine (eloralintide) to see if it can help people with overweight or obesity lose weight without having diabetes. The medicine works by affecting hormones that help control appetite and body weight.
This study tests a new medicine called eloralintide for people with type 2 diabetes who are overweight or have obesity. It aims to see if the drug can help with weight loss and blood sugar control.
This trial tests if an investigational drug called eloralintide can help people with obesity or overweight lose weight. It is for people who do not have type 2 diabetes and who have tried but struggled to lose weight on their own.
This study tests a new injection (MWN117) in healthy people and in people with obesity. It aims to see if the drug is safe and how the body handles it, which may eventually help with weight management.
Hear when a new Overweight trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.